Merck & Co., Inc. (MRK)
Last updated: 2026-10-23 23:54:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Merck & Co., Inc. (MRK) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $145.27, with a market capitalization of $369.78B and a P/E ratio of 114.49. Over the past 52 weeks, its price has ranged from $82.01 to $156.92. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$369.78B | |
$145.02 | |
$156.92 | |
$15.32 | |
$147.24 | |
6.88M | |
10.15M | |
114.49 | |
$156.92 | |
$82.01 | |
2.28% | |
-- |
Merck & Co., Inc. (MRK) After-Hours Stock Price
Merck & Co., Inc. (MRK) is trading at $144.85 in after-hours trading as of 2026-10-23 23:52:00, down 1.62% ($2.39) from the regular-session close of $147.24.
After-hours trading shows how investors are pricing MRK after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Merck & Co., Inc. (MRK) 7-Day Stock Price Change
Over the past seven days, Merck & Co., Inc. (MRK) moved from $147.37 to $145.27, representing a decline of 1.43% ($2.10).
The stock traded between $142.66 and $154.02 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 11.90 million shares, up versus the previous seven-day period, indicating higher trading activity.
MRK 52-Week Price Position
Position in Range: 84.4%
MRK is currently trading at $145.27, placing it 84.4% of the way from its 52-week low of $82.01 to its 52-week high of $156.92. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Merck & Co., Inc. (MRK)?
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
Merck & Co., Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 75000 |
| Exchange | NYSE |
| Company Website |
How to Buy Merck & Co., Inc. (MRK) Stock on MEXC
Eligible investors can buy real shares of Merck & Co., Inc. (MRK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Merck & Co., Inc. (MRK) stock price today?
2.Is MRK stock going up or down today?
3.What is MRK pre-market price?
4.What is MRK after-hours price?
5.Is MRK stock trading now?
6.Where does MRK sit relative to its 52-week high and low?
7.What sector is Merck & Co., Inc. in?
8.What is Merck & Co., Inc.'s market capitalization and where is it listed?
9.How is MRK valued in terms of P/E ratio and EPS?
10.Does Merck & Co., Inc. pay a dividend?
Explore More US Stocks
Search Stocks
MRK Stock Calculator
Estimate the value between MRK shares and USD.
MRK Shares to USD
1.00 MRK shares = 145.267 USD
Calculations are estimates based on the latest available price and are for reference only.


